Timeline
SkinBioTherapeutics restates FY25 after £0.77m fabricated royalty, HY26 revenue up 37%
Health & Bio Today: GSK, BSF Enterprise, Nuformix, Physiomics, SkinBioTherapeutics, Property Franchise Group
SkinBioTherapeutics said it's board has now completed its investigation
Health & Bio Today: GSK drops despite strong Q1, SkinBioTherapeutics, Solvonis, AstraZeneca, Ondine Biomedical
SkinBioTherapeutics says FRP forensic report imminent
SkinBioTherapeutics delays HY26 results as FRP forensic review continues on SkinBiotix platform
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.